Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.
The Nasdaq Stock Market (Nasdaq: NDAQ) has announced that trading of Moleculin Biotech, Inc. (Nasdaq: MBRX) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. The trading was halted on May 4, 2020, at 9:25:06 a.m. Eastern Time. This resumption signifies the end of the trading disruption for MBRX stocks, allowing investors to re-engage with the market.
- Trading for Moleculin Biotech, Inc. (MBRX) is set to resume, indicating potential liquidity restoration for investors.
- None.
NEW YORK, May 27, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading in Moleculin Biotech, Inc. (Nasdaq: MBRX) is scheduled to resume on Thursday, May 28, 2020, at 7:00 a.m. Eastern Time. Trading in the company’s stock was halted on May 4, 2020 at 9:25:06 Eastern Time.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
NDAQO
Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com
FAQ
When will trading resume for Moleculin Biotech (MBRX) on Nasdaq?
Why was trading halted for Moleculin Biotech?
What time was trading halted for MBRX?